The Siderophore Ferricrocin Mediates Iron Acquisition in Aspergillus fumigatus.

Aspergillus fumigatus ferricrocin fungi germination iron molds siderophore

Journal

Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614

Informations de publication

Date de publication:
15 06 2023
Historique:
medline: 19 6 2023
pubmed: 18 5 2023
entrez: 18 5 2023
Statut: ppublish

Résumé

The opportunistic fungal pathogen Aspergillus fumigatus utilizes two high-affinity iron uptake mechanisms, termed reductive iron assimilation (RIA) and siderophore-mediated iron acquisition (SIA). The latter has been shown to be crucial for virulence of this fungus and is a target for development of novel strategies for diagnosis and treatment of fungal infections. So far, research on SIA in this mold focused mainly on the hyphal stage, revealing the importance of extracellular fusarinine-type siderophores in iron acquisition as well as of the siderophore ferricrocin in intracellular iron handling. The current study aimed to characterize iron acquisition during germination. High expression of genes involved in biosynthesis and uptake of ferricrocin in conidia and during germination, independent of iron availability, suggested a role of ferricrocin in iron acquisition during germination. In agreement, (i) bioassays indicated secretion of ferricrocin during growth on solid media during both iron sufficiency and limitation, (ii) ferricrocin was identified in the supernatant of conidia germinating in liquid media during both iron sufficiency and limitation, (iii) in contrast to mutants lacking all siderophores, mutants synthesizing ferricrocin but lacking fusarinine-type siderophores were able to grow under iron limitation in the absence of RIA, and (iv) genetic inactivation of the ferricrocin transporter Sit1 decreased germination in the absence of RIA. Taken together, this study revealed that ferricrocin has not only an intracellular role but also functions as an extracellular siderophore to support iron acquisition. The iron availability-independent ferricrocin secretion and uptake during early germination indicate developmental, rather than iron regulation.

Identifiants

pubmed: 37199664
doi: 10.1128/spectrum.00496-23
pmc: PMC10269809
doi:

Substances chimiques

Siderophores 0
ferricrocin 23086-46-6
Ferrichrome 15630-64-5
fusarinine 11115-85-8
Iron E1UOL152H7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0049623

Subventions

Organisme : Austrian Science Fund FWF
ID : W 1253
Pays : Austria

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Appl Environ Microbiol. 2011 Jul;77(14):4959-66
pubmed: 21622789
Appl Environ Microbiol. 2010 Sep;76(18):6313-7
pubmed: 20656854
Appl Environ Microbiol. 2000 Nov;66(11):4810-6
pubmed: 11055928
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Eukaryot Cell. 2012 Nov;11(11):1333-44
pubmed: 22903978
Curr Opin Microbiol. 2011 Aug;14(4):400-5
pubmed: 21724450
Adv Genet. 1953;5:141-238
pubmed: 13040135
PLoS Pathog. 2010 Sep 30;6(9):e1001124
pubmed: 20941352
Metallomics. 2012 Dec;4(12):1262-70
pubmed: 23151814
Appl Environ Microbiol. 2009 Jun;75(12):4194-6
pubmed: 19376908
Sci Rep. 2019 Feb 26;9(1):2818
pubmed: 30808981
Met Ions Biol Syst. 1998;35:147-86
pubmed: 9444761
Biochim Biophys Acta Mol Cell Res. 2021 Jan;1868(1):118885
pubmed: 33045305
J Trace Elem Med Biol. 2018 Jul;48:118-133
pubmed: 29773170
Curr Opin Infect Dis. 2022 Dec 1;35(6):485-492
pubmed: 35942851
Mol Microbiol. 2001 Sep;41(5):1077-89
pubmed: 11555288
Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):E497-504
pubmed: 22106303
Biometals. 2004 Dec;17(6):647-54
pubmed: 15689108
J Biotechnol. 2010 Nov;150(3):307-11
pubmed: 20851153
Genome Biol. 2014;15(12):550
pubmed: 25516281
Genetics. 2019 Mar;211(3):893-911
pubmed: 30647069
Biochem J. 2016 May 1;473(9):1203-13
pubmed: 26929401
Eukaryot Cell. 2006 Oct;5(10):1596-603
pubmed: 17030991
Int J Mol Sci. 2021 Jul 20;22(14):
pubmed: 34299357
Mol Microbiol. 2010 Mar;75(5):1260-71
pubmed: 20070524
Mol Microbiol. 2008 Oct;70(1):27-43
pubmed: 18721228
Clin Microbiol Rev. 2019 Nov 13;33(1):
pubmed: 31722890
Front Microbiol. 2017 Mar 17;8:418
pubmed: 28367141
Mol Microbiol. 2003 Jul;49(2):359-75
pubmed: 12828635
Nat Microbiol. 2016 Nov 14;2:16211
pubmed: 27841851
BMC Genomics. 2016 May 17;17:358
pubmed: 27185182
Gene. 1983 Dec;26(2-3):205-21
pubmed: 6368319
mBio. 2022 Oct 26;13(5):e0219222
pubmed: 36125294
PLoS Pathog. 2007 Sep 28;3(9):1195-207
pubmed: 17845073
Eukaryot Cell. 2006 Jan;5(1):212-5
pubmed: 16400185
J Biol Chem. 2017 Aug 4;292(31):12727-12734
pubmed: 28615456
Fungal Genet Biol. 2011 Nov;48(11):1027-33
pubmed: 21840411
Nat Prod Rep. 2014 Oct;31(10):1266-76
pubmed: 25140791
J Fungi (Basel). 2020 May 29;6(2):
pubmed: 32485852
Antimicrob Agents Chemother. 2019 Sep 23;63(10):
pubmed: 31405865
J Exp Med. 2004 Nov 1;200(9):1213-9
pubmed: 15504822
Annu Rev Phytopathol. 2008;46:149-87
pubmed: 18680426
J Fungi (Basel). 2021 Sep 16;7(9):
pubmed: 34575806
Chembiochem. 2005 Apr;6(4):601-11
pubmed: 15719346
Science. 1974 May 31;184(4140):952-6
pubmed: 4596821
PLoS Genet. 2019 Sep 16;15(9):e1008379
pubmed: 31525190
Fungal Genet Biol. 2018 Jul;116:62-72
pubmed: 29705402
Nucl Med Biol. 2012 Apr;39(3):361-9
pubmed: 22172389
Fungal Genet Biol. 2006 Jan;43(1):42-53
pubmed: 16376592
EMBO J. 2014 Oct 1;33(19):2261-76
pubmed: 25092765

Auteurs

Isidor Happacher (I)

Institute of Molecular Biology, Biocenter, Medical University Innsbruck, Innsbruck, Austria.

Mario Aguiar (M)

Institute of Molecular Biology, Biocenter, Medical University Innsbruck, Innsbruck, Austria.

Mostafa Alilou (M)

Institute of Pharmacy, Unit of Pharmacognosy, Center for Molecular Biosciences Innsbruck, Austria.

Beate Abt (B)

Institute of Molecular Biology, Biocenter, Medical University Innsbruck, Innsbruck, Austria.

Tim J H Baltussen (TJH)

Department of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Centre of Expertise in Mycology, Radboudumc/CWZ, Nijmegen, The Netherlands.

Clemens Decristoforo (C)

Department of Nuclear Medicine, Medical University Innsbruck, Innsbruck, Austria.

Willem J G Melchers (WJG)

Department of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Centre of Expertise in Mycology, Radboudumc/CWZ, Nijmegen, The Netherlands.

Hubertus Haas (H)

Institute of Molecular Biology, Biocenter, Medical University Innsbruck, Innsbruck, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH